Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials
Lower respiratory tract infections and tuberculosis are responsible for the death of about 4.5 million people each year and are the main causes of mortality in children under 5 years of age. Streptococcus pneumoniae is the most common bacterial pathogen associated with severe pneumonia, although oth...
Main Authors: | Roberto Vázquez, Ernesto García, Pedro García |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.02252/full |
Similar Items
-
Bacteriophage lysins as antibacterials
by: Umender Sharma, et al.
Published: (2017-05-01) -
Novel phage lysin Abp013 against Acinetobacter baumannii
by: Chu, Joash Jun Keat, et al.
Published: (2022) -
Development of Phage Lysins as Novel Therapeutics: A Historical Perspective
by: Vincent A. Fischetti
Published: (2018-06-01) -
Novel Phage Lysin Abp013 against <i>Acinetobacter baumannii</i>
by: Joash Jun Keat Chu, et al.
Published: (2022-01-01) -
What’s in a Name? An Overview of the Proliferating Nomenclature in the Field of Phage Lysins
by: Roberto Vázquez, et al.
Published: (2023-08-01)